Don't Bridge Patients Most Afib Patients With Enoxaparin
You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.
Up to 1 in 6 patients are bridged when warfarin is temporarily stopped before a procedure...hoping to prevent thrombosis or stroke.
But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote